Ongoing Diagnostic Accuracy Assessment & Program Improvements
An ongoing documented quality assurance program has been implemented to ensure accurate results by correlating each type of screening exam performed to an appropriate diagnostic standard.
Quality Assurance Correlation Study Policy
A Registered Vascular Technologist performed a screening exam per Futura Health Screening’s protocol. The screening exam was either a carotid artery disease (stroke) screening exam, or an abdominal aortic aneurysm (AAA) screening exam or a peripheral arterial disease (PAD) screening exam. A report was generated, reviewed and then signed by a physician interpreter.
The screening participant was evaluated the same day by Pacific Vascular, Inc. (PVI), a vascular laboratory who provides comprehensive cerebrovascular, peripheral arterial, peripheral venous and abdominal vascular testing. PVI laboratories are ICAVL accredited and staffed by Registered Vascular Technologists. The RVT performing the full diagnostic exam was not the same technologist as the screening RVT.
The results of PVI’s cerebrovascular evaluation (which included bilateral and complete physiologic testing and duplex scanning of the extracranial arteries and complete transcranial Doppler of the intracranial arteries, when accessible) were compared to the carotid artery screening results.
The results of PVI’s abdominal aortic aneurysm evaluation (which included complete duplex scanning of the abdominal aorta, iliac and popliteal arteries) were compared to the AAA screening results.
The results of PVI’s ankle/brachial indices were compared to the PAD screening results.
The results of PVI’s full diagnostic vascular study final report were considered the “gold standard”. If there was a disagreement between the full diagnostic report and the screening results, the charts and video tapes of the exam were reviewed by Julie Menkens, RVT.
Julie Menkens, RVT was responsible for reviewing and correlating the data.
Correlation Study Results
